Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperidine-1-yl)-4-oxoquinoline-3-carboxylic Acid
2. Q 35
3. Q-35
1. 127294-70-6
2. 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
3. Balofloxacin [inn]
4. Bilimin
5. Q022b63jpm
6. (+-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)piperidino)-4-oxo-3-quinolinecarboxylic Acid
7. 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxoquinoline-3-carboxylic Acid
8. Ncgc00167532-01
9. Dsstox_cid_26695
10. Dsstox_rid_81829
11. Unii-q022b63jpm
12. Dsstox_gsid_46695
13. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo-
14. Q 35
15. (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)piperidino]-4-oxo-3-quinolinecarboxylic Acid
16. 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
17. Cas-127294-70-6
18. Chembl1210954
19. (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)piperidino)-4-oxo-3-quinolinecarboxylic Acid
20. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)-1-piperidinyl]-4-oxo-
21. Balofloxacin [mi]
22. Balofloxacin [mart.]
23. Balofloxacin [who-dd]
24. Balofloxacin 2-hydrate
25. Schembl134163
26. Dtxsid5046695
27. Hms3655n15
28. Hy-b0159
29. Rkl10070
30. Tox21_112529
31. Mfcd00864925
32. S2064
33. Akos015900452
34. Tox21_112529_1
35. Ccg-268516
36. Cs-1991
37. Ks-5214
38. Ncgc00167532-02
39. (+-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)piperidino)-4-oxo-3-quinoline Arboxylic Acid
40. 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)-1-piperidino]-4-oxo-3-quinolinecarboxylicacid
41. 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)-1-piperidyl]-4-oxo-quinoline-3-carboxylic Acid
42. B4354
43. Ft-0602907
44. Sw220155-1
45. Ab01566884_01
46. Balofloxacin, Vetranal(tm), Analytical Standard
47. 294b706
48. A805677
49. Sr-01000872576
50. J-700148
51. Q3633495
52. Sr-01000872576-1
53. 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylaminopiperidin-1-yl)-4-oxoquinoline-3-carboxylic Acid
54. 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)-1-piperidyl]-4-oxoquinoline-3-carboxylic Acid
55. 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[3-(methylamino)piperidino]-4-oxo-3-quinolinecarboxylic Acid
56. 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid
Molecular Weight | 389.4 g/mol |
---|---|
Molecular Formula | C20H24FN3O4 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 389.17508442 g/mol |
Monoisotopic Mass | 389.17508442 g/mol |
Topological Polar Surface Area | 82.1 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 668 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Market Place
ABOUT THIS PAGE
A Balofloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Balofloxacin, including repackagers and relabelers. The FDA regulates Balofloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Balofloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Balofloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Balofloxacin supplier is an individual or a company that provides Balofloxacin active pharmaceutical ingredient (API) or Balofloxacin finished formulations upon request. The Balofloxacin suppliers may include Balofloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Balofloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Balofloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Balofloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Balofloxacin GMP manufacturer or Balofloxacin GMP API supplier for your needs.
A Balofloxacin CoA (Certificate of Analysis) is a formal document that attests to Balofloxacin's compliance with Balofloxacin specifications and serves as a tool for batch-level quality control.
Balofloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Balofloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Balofloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Balofloxacin EP), Balofloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Balofloxacin USP).
LOOKING FOR A SUPPLIER?